| Understanding HSV‐1 entry glycoproteins A Reske, G Pollara, C Krummenacher, BM Chain, DR Katz Reviews in medical virology 17 (3), 205-215, 2007 | 182 | 2007 |
| Herpes simplex virus infection of dendritic cells: balance among activation, inhibition, and immunity G Pollara, K Speidel, L Samady, M Rajpopat, Y McGrath, J Ledermann, ... The Journal of infectious diseases 187 (2), 165-178, 2003 | 156 | 2003 |
| Is hepatitis C virus infection of dendritic cells a mechanism facilitating viral persistence? I Pachiadakis, G Pollara, BM Chain, NV Naoumov The Lancet infectious diseases 5 (5), 296-304, 2005 | 125 | 2005 |
| Keep calm and carry on learning: using Microsoft teams to deliver a medical education programme during the COVID-19 pandemic D Henderson, H Woodcock, J Mehta, N Khan, V Shivji, C Richardson, ... Future healthcare journal 7 (3), e67, 2020 | 120 | 2020 |
| Herpes simplex virus type-1-induced activation of myeloid dendritic cells: the roles of virus cell interaction and paracrine type I IFN secretion G Pollara, M Jones, ME Handley, M Rajpopat, A Kwan, RS Coffin, ... The Journal of Immunology 173 (6), 4108-4119, 2004 | 117 | 2004 |
| Diagnostic ‘omics’ for active tuberculosis CT Haas, JK Roe, G Pollara, M Mehta, M Noursadeghi BMC medicine 14, 1-19, 2016 | 86 | 2016 |
| Dendritic cells in viral pathogenesis: protective or defective? G Pollara, A Kwan, PJ Newton, ME Handley, BM Chain, DR Katz International journal of experimental pathology 86 (4), 187-204, 2005 | 79 | 2005 |
| Cancer–testis antigen expression in primary cutaneous melanoma has independent prognostic value comparable to that of Breslow thickness, ulceration and mitotic rate S Svobodová, J Browning, D MacGregor, G Pollara, RA Scolyer, R Murali, ... European journal of cancer 47 (3), 460-469, 2011 | 67 | 2011 |
| Molecular signatures of regression of the canine transmissible venereal tumor D Frampton, H Schwenzer, G Marino, LM Butcher, G Pollara, ... Cancer cell 33 (4), 620-633. e6, 2018 | 63 | 2018 |
| Glycoprotein-dependent and TLR2-independent innate immune recognition of herpes simplex virus-1 by dendritic cells A Reske, G Pollara, C Krummenacher, DR Katz, BM Chain The Journal of Immunology 180 (11), 7525-7536, 2008 | 63 | 2008 |
| Genomic investigations of unexplained acute hepatitis in children S Morfopoulou, S Buddle, OE Torres Montaguth, L Atkinson, ... Nature 617 (7961), 564-573, 2023 | 61 | 2023 |
| The host response to herpes simplex virus infection G Pollara, DR Katz, BM Chain Current Opinion in Infectious Diseases 17 (3), 199-203, 2004 | 61 | 2004 |
| Blood transcriptional biomarkers of acute viral infection for detection of pre-symptomatic SARS-CoV-2 infection: a nested, case-control diagnostic accuracy study RK Gupta, J Rosenheim, LC Bell, A Chandran, JA Guerra-Assuncao, ... The Lancet Microbe 2 (10), e508-e517, 2021 | 57 | 2021 |
| In vivo molecular dissection of the effects of HIV-1 in active tuberculosis LCK Bell, G Pollara, M Pascoe, GS Tomlinson, RJ Lehloenya, J Roe, ... PLoS pathogens 12 (3), e1005469, 2016 | 56 | 2016 |
| Exclusion of bacterial co-infection in COVID-19 using baseline inflammatory markers and their response to antibiotics CY Mason, T Kanitkar, CJ Richardson, M Lanzman, Z Stone, T Mahungu, ... Journal of Antimicrobial Chemotherapy 76 (5), 1323-1331, 2021 | 52 | 2021 |
| The differential influence of allogeneic tumor cell death via DNA damage on dendritic cell maturation and antigen presentation AN Rad, G Pollara, SMA Sohaib, C Chiang, BM Chain, DR Katz Cancer research 63 (16), 5143-5150, 2003 | 50 | 2003 |
| Intravenous catheter-related adverse events exceed drug-related adverse events in outpatient parenteral antimicrobial therapy J Underwood, M Marks, S Collins, S Logan, G Pollara Journal of Antimicrobial Chemotherapy 74 (3), 787-790, 2019 | 48 | 2019 |
| Attitudes and behaviours to antimicrobial prescribing following introduction of a smartphone app P Panesar, A Jones, A Aldous, K Kranzer, E Halpin, H Fifer, B Macrae, ... PloS one 11 (4), e0154202, 2016 | 48 | 2016 |
| JNK activation limits dendritic cell maturation in response to reactive oxygen species by the induction of apoptosis ME Handley, M Thakker, G Pollara, BM Chain, DR Katz Free Radical Biology and Medicine 38 (12), 1637-1652, 2005 | 44 | 2005 |
| Rapid synchronous type 1 IFN and virus-specific T cell responses characterize first wave non-severe SARS-CoV-2 infections A Chandran, J Rosenheim, G Nageswaran, L Swadling, G Pollara, ... Cell Reports Medicine 3 (3), 2022 | 42 | 2022 |
Benny ChainUCLVerified email at ucl.ac.uk
